Listed@ASX
Your go-to source for ASX IPO and listed company news, insights and analysis
Just launched! The Spring 2024 edition of Listed@ASX is now live.
Read below to view the articles, featuring a fantastic breadth of interviews with leading CEOs from ASX listed companies and more.
The cover feature for this edition is Christian Behrenbruch from Telix Pharmaceuticals (ASX:TLX). Read his story and learn about how the company will change the lives of around 150,000 cancer patients this year alone, and is set to change the lives of millions more.
Featuring the latest news and insights from Light & Wonder, a focus on the Guzman Y Gomez listing, and looking back at five years of ASX in New Zealand.
The well-honed group of advisers who supported the eight week IPO for GYG (ASX:GYG), reflect on what made the deal a success and what it indicates for other aspiring businesses
Find out why a secondary listing made sense, L&Ws Australian gaming business, responsible gaming and more. Giri Tenneti, Senior Manager, Listed Company Services - ASX, sat down with Matthew Wilson, CEO and President of Light & Wonder (ASX:LNW) to talk about the company's strategy.
June 2024 marked five years since ASX opened an office in New Zealand. During this time, 16 New Zealand companies have listed, raising over $1.26 billion in growth capital and with a combined market cap of over $7 billion. As ASX gets ready to list more New Zealand businesses in 2025, Kiwi success stories reflect on what an ASX listing means to them.
Giri Tenneti speaks to Australian Clinical Labs CEO, Melinda McGrath.
Giri Tenneti speaks to Richard White, Founder and CEO of Wisetech Global
For more information contact the ASX Listings team.
Sign up for Listed@ASX
Your go-to source for ASX IPO and listed company news, insights and analysis - straight to your inbox three time a year.
For more information contact the ASX Listings team.
The views, opinions or recommendations of the author in this article are solely those of the author and do not in any way reflect the views, opinions, recommendations, of ASX Limited ABN 98 008 624 691 and its related bodies corporate (“ASX”). ASX makes no representation or warranty with respect to the accuracy, completeness or currency of the content. The content is for educational purposes only and does not constitute financial advice. Independent advice should be obtained from an Australian financial services licensee before making investment decisions. To the extent permitted by law, ASX excludes all liability for any loss or damage arising in any way due to or in connection with the publication of this article, including by way of negligence.
